We are live on ! Find out more
IMI

Intermolecular, Inc.
IMI

Delisted

IMI was delisted on the 19th of September, 2019.

Back to rankings

20 hedge funds and large institutions have $19M invested in Intermolecular, Inc. in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $17.4M → $19M (+$1.56M)

13% less funds holding

Funds holding: 23 → 20 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5

Holders
20
Holders Change
-3
Holders Change %
-13.04%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$17K
2
ISL
Ingalls & Snyder LLC
New York
+$9.42K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$18

Top Sellers

Rank Fund Capital Flow
1
AL
Aspiriant LLC
California
-$61K
2
PAM
Panagora Asset Management
Massachusetts
-$45K
3
SIM
Spark Investment Management
New York
-$37.5K
4
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$25K
5
BlackRock
BlackRock
New York
-$15.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Raging Capital Management
New Jersey
$15M – – –
SPM
2
Symmetry Peak Management
Pennsylvania
$1.04M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$869K +$17K +18,000 +2%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$642K -$8.13K -8,634 -1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$523K – – –
RA
6
Royce & Associates
New York
$286K – – –
BCM
7
Bridgeway Capital Management
Texas
$253K – – –
BlackRock
8
BlackRock
New York
$72K -$15.4K -16,368 -19%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$70K – – –
SIM
10
Spark Investment Management
New York
$58K -$37.5K -39,785 -41%
RC
11
RBF Capital
California
$45K – – –
Northern Trust
12
Northern Trust
Illinois
$37K – – –
Creative Planning
13
Creative Planning
Kansas
$34K – – –
GC
14
Guggenheim Capital
Illinois
$11K -$25 -27 -0.2%
ISL
15
Ingalls & Snyder LLC
New York
$10K +$9.42K +10,000 New
CPA
16
Cowen Prime Advisors
New York
$3K – – –
TSW
17
Thompson Siegel & Walmsley
Virginia
$2K – – –
AL
18
Aspiriant LLC
California
– -$61K -67,246 Closed
PAM
19
Panagora Asset Management
Massachusetts
– -$45K -48,786 Closed
SKK
20
Shepherd Kaplan Krochuk
Massachusetts
– -$25K -27,607 Closed
TRCT
21
Tower Research Capital (TRC)
New York
– -$12K -13,648 Closed
UBS Group
22
UBS Group
Switzerland
– -$8K -8,484 Closed
Morgan Stanley
23
Morgan Stanley
New York
– -$116 -123 -58%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
– +$18 +19 New

IMI Hedge Fund Activity: Q3 2017 in Review

20 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Intermolecular, Inc. (IMI) for Q3 2017, worth a combined $19M — up 8.9% from $17.4M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IMI and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $17K. The largest seller was Aspiriant LLC, exiting entirely with an estimated $61K sold.

  • 20 institutional investors held Intermolecular, Inc. (IMI) as of Q3 2017, down from 23 in Q2 2017.
  • Funds reported $19M of Intermolecular, Inc. stock for Q3 2017, up 8.9% quarter-over-quarter.
  • 2 funds opened new Intermolecular, Inc. positions in Q3 2017 and 5 closed out, a net change of -3 holders.
  • The largest Intermolecular, Inc. buyer in Q3 2017 was Renaissance Technologies, an estimated $17K added.
  • The largest Intermolecular, Inc. seller in Q3 2017 was Aspiriant LLC, an estimated $61K sold.

Based on aggregated 13F filings for Q3 2017.